Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability.

Antibodies (Basel) · 2022 · PMC8788544 · PMID 35076451

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although each approach was successful in generating EGFR binders with increased humanness, there was a clear trend in stability and affinity retention across the humanization strategies.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.